Canigen DHA2PPi/LR liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań dla psów
Canigen DHA2PPi/LR liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań dla psów
Viðurkennt
- Canine parvovirus, strain Cornell 780916, Live
- Canine adenovirus 2, strain Manhattan, Live
- Canine distemper virus, strain Lederle VR128, Live
- Canine parainfluenza virus, strain Manhattan, Live
- Rabies virus, strain VP12, Inactivated
Auðkenning lyfsins
Upplýsingar um lyfið
Virkt efni / Styrkur:
-
Aðeins í boði í English10000000.00/tissue culture infective dose 501.00tissue culture infective dose 50
-
Aðeins í boði í English1000000.00/tissue culture infective dose 501.00tissue culture infective dose 50
-
Aðeins í boði í English100000.00/tissue culture infective dose 501.00tissue culture infective dose 50
-
Aðeins í boði í English10000000.00/tissue culture infective dose 501.00tissue culture infective dose 50
-
Aðeins í boði í English1.00/international unit(s)1.00international unit(s)
Lyfjaform:
-
Frostþurrkað stungulyf og leysir, dreifa
Withdrawal period by route of administration:
-
Til notkunar undir húð
- Hundur
-
Engin gögn veitt
-
ATC flokkun (dýralyf):
- QI07A
Lögformleg staða:
-
Ávísunarskylt dýralyf
Staða markaðsleyfis:
-
Gilt
Authorised in:
-
Pólland
Viðbótarupplýsingar
Entitlement type:
-
Marketing Authorisation
Markaðsleyfishafi:
- Virbac
Marketing authorisation date:
Framleiðandi sem ber ábyrgð á lokasamþykkt:
- VIRBAC
Ábyrgt yfirvald:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Markaðsleyfisnúmer:
- 1484
Dagsetning leyfisbreytingar:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Hversu gagnlegt var þessi síða?:
